Published in Transplantation on October 01, 2017
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med (2014) 3.04
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology (2014) 2.14
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology (2012) 1.74
Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl (2003) 1.64
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. Liver Transpl (2012) 1.54
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl (2011) 1.52
A case of adult hepatic toxocariasis. Nat Clin Pract Gastroenterol Hepatol (2008) 1.51
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl (2007) 1.46
Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. J Vasc Interv Radiol (2013) 1.41
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation (2008) 1.20
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty (2005) 1.15
Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int (2009) 1.12
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. Liver Transpl (2012) 1.10
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology (2011) 1.09
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol (2013) 1.08
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol (2012) 1.06
Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause (2004) 1.05
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology (2012) 1.03
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol (2013) 1.02
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology (2009) 1.01
The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology (2004) 1.00
Bacterial infections in end-stage liver disease: current challenges and future directions. Gut (2012) 1.00
Cross-talk of alloimmune response and autoimmunity: role in pathogenesis of chronic rejection. Discov Med (2010) 1.00
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med (2016) 0.97
Overview of immunosuppression in liver transplantation. World J Gastroenterol (2009) 0.96
Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Hepatology (2013) 0.95
Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop. Am J Gastroenterol (2010) 0.95
Cost savings of performing paracentesis procedures at the bedside after simulation-based education. Simul Healthc (2014) 0.94
The cumulative effects of cold ischemic time and older donor age on liver graft survival. J Surg Res (2008) 0.93
Epstein-barr virus: an unusual cause of cholestatic hepatitis in older adults. Gastroenterol Hepatol (N Y) (2007) 0.92
The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl (2003) 0.91
Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol (2013) 0.90
Pepsin detection in patients with laryngopharyngeal reflux before and after fundoplication. Surg Endosc (2011) 0.89
Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities. Technol Cancer Res Treat (2009) 0.88
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl (2012) 0.88
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study. Transplantation (2015) 0.88
The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transpl (2003) 0.87
Laparoscopy as the initial approach for epiphrenic diverticula. Surg Endosc (2011) 0.87
Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl (2011) 0.86
Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography. Transplantation (2008) 0.85
Hepatitis C genotype influences post-liver transplant outcomes. Transplantation (2015) 0.85
Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes. Transplantation (2014) 0.85
A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study. Transplantation (2016) 0.85
Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease. Therap Adv Gastroenterol (2012) 0.84
A case of biliopleural fistula in a patient with hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2009) 0.84
Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients. Liver Transpl (2013) 0.83
Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus. Liver Transpl (2012) 0.83
Predicting surgical risk in patients with cirrhosis: from art to science. Gastroenterology (2007) 0.82
Racial differences in fibrosis progression after HCV-related liver transplantation. Transplantation (2012) 0.82
Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease. J Clin Gastroenterol (2014) 0.82
Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol (2014) 0.82
Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation. Liver Transpl (2002) 0.82
Successful, combined long-term treatment of cerebral aspergillosis in a liver transplant patient. Virulence (2010) 0.81
Specialties performing paracentesis procedures at university hospitals: implications for training and certification. J Hosp Med (2014) 0.81
Gastroenterology training in a resource-limited setting: Zambia, Southern Africa. World J Gastroenterol (2013) 0.80
Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil. Liver Transpl (2007) 0.80
ABO-compatible liver allograft antibody-mediated rejection: an update. Curr Opin Organ Transplant (2015) 0.78
Multiphase Multi-Detector Row Computed Tomography Imaging Characteristics of Large (>5 cm) Focal Hepatocellular Carcinoma. J Comput Assist Tomogr (2016) 0.78
Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant (2002) 0.77
The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant (2014) 0.76
Use of protease inhibitors in liver transplant recipients. Gastroenterol Hepatol (N Y) (2012) 0.76
23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker. Crit Care Med (2016) 0.76
Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'. Curr Opin Organ Transplant (2016) 0.76
Post-liver transplant hepatitis C therapy. Curr Treat Options Gastroenterol (2015) 0.76
Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation (2015) 0.76
Role of extended lymphadenectomy in the treatment of pancreatic head adenocarcinoma: review and meta-analysis. ANZ J Surg (2013) 0.75
Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transplant (2007) 0.75
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol (2016) 0.75
The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol (2016) 0.75
Is MELD fit enough? Gastroenterology (2011) 0.75
Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation (2016) 0.75
Effect of standardized medication-order forms on medication errors after liver or kidney transplantation. Am J Health Syst Pharm (2012) 0.75
Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol (2013) 0.75
Common iliac artery lying posterior to psoas major identified during kidney transplantation. Transplantation (2008) 0.75
Corrigendum: Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. Am J Gastroenterol (2016) 0.75
782: SERUM OSMOLALITY IS ASSOCIATED WITH HEPATIC ENCEPHALOPATHY SEVERITY IN PATIENTS WITH LIVER FAILURE. Crit Care Med (2016) 0.75
Management of stomal varices with transvenous obliteration utilizing sodium tetradecyl sulfate foam sclerosis. Cardiovasc Intervent Radiol (2014) 0.75
Hepatitis C treatment in patients on the liver transplant waiting list. Curr Opin Organ Transplant (2015) 0.75
25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant. Exp Clin Transplant (2014) 0.75
HCC influence on patient survival after liver transplantation for HDV cirrhosis. Hepatogastroenterology (2011) 0.75
Paraesophageal hernia: a rare presentation of Marfan syndrome in adults. Gastrointest Endosc (2007) 0.75
Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation (2017) 0.75
Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation. Urol Oncol (2005) 0.75
Osmotic Demyelination Syndrome in Hospitalized Patients With Cirrhosis: Analysis of the National Inpatient Sample (NIS). J Clin Gastroenterol (2022) 0.75